Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 893 | 2,544 | 3,856 | 5,413 | 950 |
| Receivables | 131 | 60 | 63 | 43 | 13 |
| Inventories | 197 | 17 | 8 | 18 | 18 |
| TOTAL | $1,584 | $3,084 | $4,560 | $5,577 | $1,052 |
| Non-Current Assets | |||||
| PPE Net | 197 | 180 | 173 | 136 | 156 |
| Investments And Advances | 434 | 548 | 585 | 408 | 345 |
| TOTAL | $631 | $727 | $758 | $544 | $501 |
| Total Assets | $2,215 | $3,812 | $5,318 | $6,121 | $1,553 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6 | 22 | 36 | 96 | 149 |
| Accrued Expenses | 321 | 282 | 276 | 241 | 294 |
| TOTAL | $328 | $308 | $312 | $338 | $2,352 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1 | 4 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 150 | 170 | 200 | 220 | 260 |
| TOTAL | $150 | $170 | $200 | $220 | $260 |
| Total Liabilities | $478 | $478 | $512 | $558 | $2,612 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 914 | 577 | 570 | 567 | 567 |
| Common Shares | 17 | 17 | 17 | 17 | 13 |
| Retained earnings | -24,968 | -23,155 | -21,407 | -20,063 | -18,694 |
| TOTAL | $1,737 | $3,334 | $4,806 | $5,564 | $-1,059 |
| Total Liabilities And Equity | $2,215 | $3,812 | $5,318 | $6,121 | $1,553 |